Thursday, 20 March 2014

Generic Fibromyalgia Drug & Serotonin Syndrome Risk

People taking the high-priced fibromyalgia drug Cymbalta (duloxetine) could soon have a less expensive option - the U.S. FDA in December approved a generic version which is expected to cost a lot less once it hits the market. However, a possible risk has emerged in Australia, where generic duloxetine is already on the market. Doctors there are reporting 21 confirmed cases of serotonin syndrome, which is a potentially deadly condition that doctors often miss.

Generic Fibromyalgia Drug & Serotonin Syndrome Risk

Pamela is a former accountant, recovering journalist and international cat herder, disabled and chronically sick with Myalgic Encephalomyelitis, Fibromyalgia and Cervical spondylosis, fluent in three languages; English, Spanish and Rubbish. Mostly writes in the latter. She likes Genealogy, Model Railways and Cats.

No comments:

Related Posts Plugin for WordPress, Blogger...
^ Top